UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended July 31, 2021 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File No. 1-8061 FREQUENCY ELECTRONICS, INC. (Exact name of Registrant as specified in its charter) Delaware 11-1986657 (State ...

Frequency Electronics, Inc. (NASDAQ:FEIM) Q4 2021 Earnings Conference Call June 29, 2021 4:30 PM ET Company Participants Stanton Sloane - President and Chief Executive Officer Steven Bernstein - Chief Financial Officer Conference Call Participants Brett Reiss - Janney Montgomery Scott Sam Rebotsky - SER Asset Management Michael Eisner - Private Investor Operator Greetings and welcome to the Frequency Electronics Fourth Quarter and Fiscal Year End 2021 Earnings Release Conference Call. [Operator Instructions ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended April 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File No. 1-8061 FREQUENCY ELECTRONICS, INC. (Exact name of Registrant as specified in its charter) Delaware 11-1986657 (State or o ...

Frequency Electronics, Inc. (NASDAQ:FEIM) Q3 2021 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants Stanton Sloane – President and Chief Executive Officer Steve Bernstein – Chief Financial Officer Conference Call Participants Michael Eisner – Private Investor Sam Rebotsky – SER Asset Management Brett Reiss – Janney Montgomery Scott Walter Sturm – Private Investor Joe Gersky – Private Investor Operator Greetings, and welcome to the Frequency Electronics Third Quarter Fiscal Year 2021 Ea ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended January 31, 2021 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File No. 1-8061 FREQUENCY ELECTRONICS, INC. (Exact name of Registrant as specified in its charter) Delaware 11-1986657 (St ...

Frequency Electronics, Inc. NASDAQ: FEIM Providing High-Precision Timing & Frequency Generation and RF/Microwave Technology for Space and Terrestrial Applications Stanton Sloane President & CEO Steven Bernstein CFO Needham Growth Conference 1/12/2021 Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The Statements in this presentation regarding the future constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of th ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended October 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File No. 1-8061 FREQUENCY ELECTRONICS, INC. (Exact name of Registrant as specified in its charter) Delaware 11-1986657 ( ...

[Part I. Financial Information](index=4&type=section&id=Part%20I.%20Financial%20Information) This section covers the company's financial statements, management's analysis, market risk disclosures, and internal controls [Item 1. Financial Statements](index=4&type=section&id=Item%201%20-%20Financial%20Statements) The company reported increased revenues and narrowed losses for the quarter, with stable assets and ongoing legal and regulatory matters [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) The balance sheet shows a slight decrease in total assets and liabilities, with stable stockholders' equity as of July 31, 2020 Condensed Consolidated Balance Sheet Highlights (in thousands) | Balance Sheet Item | July 31, 2020 | April 30, 2020 | | :--- | :--- | :--- | | **Total Current Assets** | $49,633 | $51,235 | | **Total Assets** | **$88,944** | **$91,276** | | **Total Current Liabilities** | $10,738 | $12,988 | | **Total Liabilities** | **$34,609** | **$37,040** | | **Total Stockholders' Equity** | **$54,335** | **$54,236** | [Condensed Consolidated Statements of Operations and Comprehensive Loss](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations%20and%20Comprehensive%20Loss) The company reported increased revenues and a narrowed operating and net loss for the three months ended July 31, 2020 Condensed Consolidated Statements of Operations (in thousands, except per share data) | Metric | Three Months Ended July 31, 2020 | Three Months Ended July 31, 2019 | | :--- | :--- | :--- | | **Revenues** | $12,951 | $12,554 | | **Gross Margin** | $4,088 | $3,953 | | **Operating Loss** | $(337) | $(780) | | **Net Loss** | **$(262)** | **$(591)** | | **Basic and Diluted Loss Per Share** | **$(0.03)** | **$(0.07)** | [Condensed Consolidated Statements of Cash Flows](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Cash flow analysis shows a net decrease in cash due to financing activities, despite positive operating and investing cash flows Condensed Consolidated Statements of Cash Flows (in thousands) | Cash Flow Activity | Three Months Ended July 31, 2020 | Three Months Ended July 31, 2019 | | :--- | :--- | :--- | | Net cash provided by operating activities | $62 | $153 | | Net cash provided by (used in) investing activities | $514 | $(1,597) | | Net cash used in financing activities | $(1,953) | $0 | | **Net decrease in cash and cash equivalents** | **$(1,377)** | **$(1,444)** | | **Cash and cash equivalents at end of period** | **$2,431** | **$2,239** | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Key notes disclose the impact of COVID-19, segment performance, an OFAC investigation, and ongoing legal proceedings with a former executive - The company is actively monitoring the impact of the COVID-19 pandemic, which has caused some vendor delays but has not significantly impacted production[30](index=30&type=chunk)[31](index=31&type=chunk) The full financial effect for fiscal year 2021 remains uncertain[32](index=32&type=chunk) - The company made a voluntary disclosure to the Office of Foreign Assets Control (OFAC) regarding untimely payments from its Russian investment, Morion, Inc., which may have violated U.S. sanctions[61](index=61&type=chunk) OFAC has initiated a civil investigation, the outcome and potential liability of which are currently unknown[62](index=62&type=chunk) - The company is engaged in litigation and arbitration with a former executive, Martin B. Bloch, over claims of wrongful termination, age discrimination, and denial of deferred compensation benefits[79](index=79&type=chunk) The company is defending itself vigorously but cannot predict the outcome or estimate potential losses[80](index=80&type=chunk) Revenue by Segment (in thousands) | Segment | Three Months Ended July 31, 2020 | Three Months Ended July 31, 2019 | | :--- | :--- | :--- | | FEI-NY | $9,839 | $9,010 | | FEI-Zyfer | $3,922 | $3,701 | | Intersegment | $(810) | $(157) | | **Total** | **$12,951** | **$12,554** | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=18&type=section&id=Item%202%20-%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses increased revenue, narrowed operating loss due to R&D reductions, and a strong liquidity position with growing backlog [Results of Operations](index=20&type=section&id=Results%20of%20Operations) Revenue increased by 3.2% driven by satellite programs, while operating loss narrowed due to reduced R&D expenses despite higher SG&A costs Revenue Analysis (in thousands) | Revenue Source | Q1 FY2021 | Q1 FY2020 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Satellite Programs | $6,651 | $3,895 | $2,756 | 70.8% | | Government Non-Space | $5,335 | $6,744 | $(1,409) | (20.9)% | | Other Commercial | $965 | $1,915 | $(950) | (49.6)% | | **Total Revenues** | **$12,951** | **$12,554** | **$397** | **3.2%** | - Selling and administrative (SG&A) expenses increased by **$775,000 (31.6%)** year-over-year, attributed to higher professional fees related to litigation and increased insurance costs[109](index=109&type=chunk) - Research and development (R&D) expenses decreased by **$1.1 million (47.5%)** compared to the prior year, as previous R&D efforts have concluded and transitioned into production phases[110](index=110&type=chunk) [Liquidity and Capital Resources](index=22&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity with $38.9 million in working capital and a growing funded backlog of $38 million - The company maintains a strong working capital position of **$38.9 million** and a current ratio of **4.6 to 1** at July 31, 2020[120](index=120&type=chunk) - Consolidated funded backlog increased to approximately **$38 million** as of July 31, 2020, up from $36 million at April 30, 2020[128](index=128&type=chunk) Approximately **81%** of this backlog is expected to be realized in the next twelve months[128](index=128&type=chunk) - Management believes that its liquidity is adequate to meet its operating and investment needs through at least September 14, 2021[129](index=129&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=24&type=section&id=Item%203%20-%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section is not applicable as the company qualifies as a smaller reporting company - Disclosure is not applicable to smaller reporting companies[133](index=133&type=chunk) [Item 4. Controls and Procedures](index=24&type=section&id=Item%204%20-%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective, with no material changes to internal control over financial reporting - The Company's chief executive officer and chief financial officer concluded that as of July 31, 2020, the Company's disclosure controls and procedures were effective[134](index=134&type=chunk) - There were no changes in the Company's internal control over financial reporting during the quarter that have materially affected, or are reasonably likely to materially affect, the controls[136](index=136&type=chunk) [Part II. Other Information](index=25&type=section&id=Part%20II.%20Other%20Information) This section details the company's ongoing legal proceedings and lists the exhibits filed with the quarterly report [Item 1. Legal Proceedings](index=25&type=section&id=Item%201%20%E2%80%93%20Legal%20Proceedings) The company is engaged in multiple legal disputes and arbitration with a former executive regarding termination and deferred compensation claims - Former Chief Scientist Martin B. Bloch filed a complaint against the Company alleging wrongful termination "for cause" and age discrimination[140](index=140&type=chunk) - Mr. Bloch also initiated two arbitration proceedings claiming denial of deferred compensation benefits under ERISA rules[141](index=141&type=chunk) - The Company has filed a petition to stay the arbitration and intends to vigorously defend against all of Mr. Bloch's allegations, but cannot determine the probability of liability or estimate any potential loss at this time[140](index=140&type=chunk)[142](index=142&type=chunk) [Item 6. Exhibits](index=26&type=section&id=Item%206%20-%20Exhibits) This section lists the exhibits filed, including CEO and CFO certifications and financial statements in XBRL format - Exhibits filed include CEO and CFO certifications pursuant to Sarbanes-Oxley Act Sections 302 and 906[145](index=145&type=chunk)[146](index=146&type=chunk) - The report includes financial data formatted in eXtensible Business Reporting Language (XBRL)[147](index=147&type=chunk)

Frequency Electronics Inc. (NASDAQ:FEIM) Q1 2021 Results Conference Call September 10, 2020 4:30 PM ET Company Participants Stanton Sloane - President and CEO Steve Bernstein - CFO Conference Call Participants Sam Rebotsky - SER Asset Management Brett Reiss - Janney Montgomery Scott Robert Smith - Center of Performance Investing Operator Greetings and welcome to the Frequency Electronics First Quarter Fiscal Year 2021 Earnings Release Conference Call. At this time all participants are in a listen-only mode. ...

PART I [Business](index=4&type=section&id=Item%201.%20Business) Frequency Electronics, Inc. provides precision time and frequency generation systems for satellite, C4ISR, and EW, with 83% of FY2020 revenue from U.S. Government contracts - The company's core business is providing precision time and low phase noise frequency generation systems for space and challenging environments[15](index=15&type=chunk)[17](index=17&type=chunk) - Operations are divided into two segments: FEI-NY, accounting for **77% of FY2020 revenues**, and FEI-Zyfer, accounting for **26%**[21](index=21&type=chunk)[29](index=29&type=chunk)[30](index=30&type=chunk) - Consolidated backlog was approximately **$36 million** as of April 30, 2020, with **81%** expected to be filled in fiscal year 2021[44](index=44&type=chunk) - Sales to the U.S. Government or subcontracts for U.S. Government end-use constituted **83% of total sales in FY2020**[46](index=46&type=chunk)[47](index=47&type=chunk) | Category | FY 2020 | FY 2019 | | :--- | :--- | :--- | | **R&D Expenditure** | $5.1 million | $6.5 million | [Risk Factors](index=10&type=section&id=Item%201A.%20Risk%20Factors) This section is not applicable as the company qualifies as a smaller reporting company - This item is not required for smaller reporting companies[68](index=68&type=chunk) [Unresolved Staff Comments](index=10&type=section&id=Item%201B.%20Unresolved%20Staff%20Comments) The company has no unresolved comments from the SEC staff - Not Applicable[69](index=69&type=chunk) [Properties](index=10&type=section&id=Item%202.%20Properties) The company leases all primary operational facilities, including its headquarters in Long Island, NY, and sites in CA and NJ | Location | Size (sq. ft.) | Own or Lease | | :--- | :--- | :--- | | Long Island, NY | 93,000 | Lease | | Garden Grove, CA | 27,850 | Lease | | Northvale, NJ | 9,000 | Lease | - The lease for the main Long Island, NY facility was extended through **September 30, 2029**[71](index=71&type=chunk) [Legal Proceedings](index=11&type=section&id=Item%203.%20Legal%20Proceedings) The company is engaged in multiple legal disputes with a former Chief Scientist regarding wrongful termination, age discrimination, and deferred compensation claims - Martin B. Bloch, former Chief Scientist, filed a complaint alleging wrongful termination and age discrimination[74](index=74&type=chunk) - Mr. Bloch also initiated two arbitration proceedings claiming denial of benefits under deferred compensation agreements[75](index=75&type=chunk) - The company has filed a petition to stay arbitration, believing the claims are without merit, and intends to vigorously defend its position[74](index=74&type=chunk)[76](index=76&type=chunk)[77](index=77&type=chunk) [Mine Safety Disclosures](index=11&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This disclosure is not applicable to the company's operations - Not applicable[78](index=78&type=chunk) PART II [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=12&type=section&id=Item%205.%20Market%20for%20Registrant%27s%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) The company's common stock trades on Nasdaq under 'FEIM'; no dividends were paid in FY2020 or FY2019, and no shares were repurchased - The company's common stock is listed on The Nasdaq Global Market under the ticker symbol **"FEIM"**[81](index=81&type=chunk) - No dividends were declared or paid during fiscal years **2020 and 2019**, with an intention to retain future earnings[82](index=82&type=chunk) - The company did not repurchase any stock during fiscal years **2020 or 2019**, with approximately **$1 million** remaining authorized under its repurchase program[83](index=83&type=chunk) [Selected Financial Data](index=12&type=section&id=Item%206.%20Selected%20Financial%20Data) This section is not applicable as the company qualifies as a smaller reporting company - Not Applicable[84](index=84&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=12&type=section&id=Item%207.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) FY2020 revenues decreased **16% to $41.5 million**, gross margin fell to **13.9%**, and operating loss widened to **$10.9 million**, driven by lower revenues and higher engineering costs [Results of Operations](index=15&type=section&id=Results%20of%20Operations) FY2020 consolidated revenues decreased **16% to $41.5 million**, gross profit fell **63.6%**, and operating loss widened to **$10.9 million**, driven by lower revenues and higher engineering costs | Metric | FY 2020 (USD thousands) | FY 2019 (USD thousands) | Change (%) | | :--- | :--- | :--- | :--- | | **Revenues** | $41,507 | $49,509 | (16%) | | **Gross Profit** | $5,748 | $15,789 | (63.6%) | | **Gross Margin** | 13.9% | 31.9% | - | | **Operating Loss** | $(10,922) | $(2,817) | NM | | **Net Loss** | $(10,026) | $(2,529) | NM | - The decrease in gross profit and margin resulted from lower revenues and increased engineering costs on development-phase programs facing technical challenges[104](index=104&type=chunk) - The company recorded an income tax benefit of **$1.74 million** in FY2020, primarily due to the CARES Act allowing for net operating loss carryback[113](index=113&type=chunk) [Liquidity and Capital Resources](index=17&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintained strong liquidity with **$38.3 million** in working capital and **$14.4 million** in cash at FY2020-end, despite **$1.4 million** net cash used in operations | Metric | April 30, 2020 (USD millions) | April 30, 2019 (USD millions) | | :--- | :--- | :--- | | **Working Capital** | $38.3 | $46.9 | | **Cash & Marketable Securities** | $14.4 | N/A | | **Current Ratio** | 3.9 to 1 | 9.0 to 1 | - Net cash used in operations was **$1.4 million** in FY2020, compared to **$0.1 million** in FY2019[115](index=115&type=chunk) - The company received a **$5.0 million** PPP loan in April 2020, which was fully repaid in May 2020[119](index=119&type=chunk)[308](index=308&type=chunk) - Management believes existing cash, marketable securities, and cash flows will provide sufficient liquidity for the next twelve months[121](index=121&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=19&type=section&id=Item%207A.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section is not applicable as the company qualifies as a smaller reporting company - Not applicable[134](index=134&type=chunk) [Financial Statements and Supplementary Data](index=19&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) This section presents the company's audited consolidated financial statements for FY2020 and FY2019, including balance sheets, statements of operations, cash flows, and comprehensive notes [Consolidated Financial Statements](index=22&type=section&id=Consolidated%20Financial%20Statements) FY2020 net loss was **$10.0 million** on **$41.5 million** revenues, with total assets of **$91.3 million**, liabilities of **$37.0 million**, and stockholders' equity of **$54.2 million** Key Financial Statement Data (USD thousands) | Account | April 30, 2020 | April 30, 2019 | | :--- | :--- | :--- | | **Total Assets** | $91,276 | $86,771 | | **Total Liabilities** | $37,040 | $23,682 | | **Total Stockholders' Equity** | $54,236 | $63,089 | | **Revenues (FY)** | $41,507 | $49,509 | | **Net Loss (FY)** | $(10,026) | $(2,529) | | **Net Cash Used in Operations (FY)** | $(1,407) | $(97) | [Notes to Consolidated Financial Statements](index=28&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) The notes detail accounting policies, including lease standard adoption, COVID-19 impact, CARES Act tax benefits, segment performance, and ongoing legal contingencies - The company adopted the new lease accounting standard (Topic 842) in FY2020, recognizing **$12.1 million** in lease liabilities and right-of-use assets[216](index=216&type=chunk)[128](index=128&type=chunk) - In FY2020, a **$1 million** reserve was recorded for a note receivable from the 2018 Gillam subsidiary sale; the FEI-Asia subsidiary sale in May 2019 resulted in a **$1 million** loss in FY2019[219](index=219&type=chunk)[220](index=220&type=chunk) - The company recorded an income tax benefit of **$1.74 million** in FY2020, primarily due to the CARES Act allowing for net operating loss carryback[273](index=273&type=chunk)[277](index=277&type=chunk)[279](index=279&type=chunk) Segment Operating Loss (FY 2020, USD thousands) | Segment | Operating Loss | | :--- | :--- | | FEI-NY | $(9,910) | | FEI-Zyfer | $(673) | | Corporate | $(339) | | **Consolidated Total** | **$(10,922)** | [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](index=50&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20with%20Accountants%20on%20Accounting%20and%20Financial%20Disclosure) The company reported no disagreements with its accountants on accounting principles, financial disclosure, or auditing scope - None[310](index=310&type=chunk) [Controls and Procedures](index=50&type=section&id=Item%209A.%20Controls%20and%20Procedures) As of April 30, 2020, management concluded that both disclosure controls and internal control over financial reporting were effective - Management concluded that the company's disclosure controls and procedures were effective as of **April 30, 2020**[311](index=311&type=chunk) - Management assessed the company's internal control over financial reporting as effective as of **April 30, 2020**, based on the COSO framework[313](index=313&type=chunk) [Other Information](index=50&type=section&id=Item%209B.%20Other%20Information) There was no other information to be reported in this section - None[316](index=316&type=chunk) PART III Part III incorporates information by reference from the company's 2020 Proxy Statement, covering directors, executive officers, corporate governance, compensation, security ownership, and accountant fees [Directors, Executive Officers and Corporate Governance](index=51&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20and%20Corporate%20Governance) Information on directors, executive officers, corporate governance, and Section 16(a) compliance is incorporated by reference from the 2020 Proxy Statement - Information required by this item is incorporated by reference from the company's definitive proxy statement for the annual meeting of stockholders[319](index=319&type=chunk) [Executive Compensation](index=51&type=section&id=Item%2011.%20Executive%20Compensation) This information is incorporated by reference from the company's 2020 Proxy Statement - This item is incorporated by reference from the Company's 2020 Proxy Statement[320](index=320&type=chunk) [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](index=51&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management%20and%20Related%20Stockholder%20Matters) This information is incorporated by reference from the company's 2020 Proxy Statement - This item is incorporated by reference from the Company's 2020 Proxy Statement[320](index=320&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=51&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) This information is incorporated by reference from the company's 2020 Proxy Statement - This item is incorporated by reference from the Company's 2020 Proxy Statement[321](index=321&type=chunk) [Principal Accountant Fees and Services](index=51&type=section&id=Item%2014.%20Principal%20Accountant%20Fees%20and%20Services) This information is incorporated by reference from the company's 2020 Proxy Statement - This item is incorporated by reference from the Company's 2020 Proxy Statement[321](index=321&type=chunk) PART IV This final part lists the financial statements and exhibits filed as part of the annual report, including signatures of officers and directors [Exhibits and Financial Statement Schedules](index=52&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section provides an index of financial statements and all exhibits filed with the Form 10-K, including corporate governance documents and certifications - Lists the financial statements and exhibits filed as part of the annual report[325](index=325&type=chunk) [Form 10-K Summary](index=55&type=section&id=Item%2016.%20Form%2010-K%20Summary) No summary is provided in this section - None[330](index=330&type=chunk)